Cargando…
Selected nucleos(t)ide-based prescribed drugs and their multi-target activity
Nucleos(t)ide analogues play pivotal roles as antiviral, cytotoxic or immunosuppressive agents. Here, we review recent reports of nucleoside analogues that exhibit broad-spectrum activity towards multiple life-threatening RNA and DNA viruses. We also present a discussion about nucleoside antimetabol...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier B.V.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173238/ https://www.ncbi.nlm.nih.gov/pubmed/31634460 http://dx.doi.org/10.1016/j.ejphar.2019.172747 |
_version_ | 1783524413400940544 |
---|---|
author | Pastuch-Gawołek, Gabriela Gillner, Danuta Król, Ewelina Walczak, Krzysztof Wandzik, Ilona |
author_facet | Pastuch-Gawołek, Gabriela Gillner, Danuta Król, Ewelina Walczak, Krzysztof Wandzik, Ilona |
author_sort | Pastuch-Gawołek, Gabriela |
collection | PubMed |
description | Nucleos(t)ide analogues play pivotal roles as antiviral, cytotoxic or immunosuppressive agents. Here, we review recent reports of nucleoside analogues that exhibit broad-spectrum activity towards multiple life-threatening RNA and DNA viruses. We also present a discussion about nucleoside antimetabolites—approved antineoplastic agents—that have recently been shown to have antiviral and/or antibacterial activity. The approved drugs and drug combinations, as well as recently identified candidates for investigation and/or experimentation, are discussed. Several examples of repurposed drugs that have already been approved for use are presented. This strategy can be crucial for the first-line treatment of acute infections or coinfections and for the management of drug-resistant strains. |
format | Online Article Text |
id | pubmed-7173238 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | The Authors. Published by Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71732382020-04-22 Selected nucleos(t)ide-based prescribed drugs and their multi-target activity Pastuch-Gawołek, Gabriela Gillner, Danuta Król, Ewelina Walczak, Krzysztof Wandzik, Ilona Eur J Pharmacol Full Length Article Nucleos(t)ide analogues play pivotal roles as antiviral, cytotoxic or immunosuppressive agents. Here, we review recent reports of nucleoside analogues that exhibit broad-spectrum activity towards multiple life-threatening RNA and DNA viruses. We also present a discussion about nucleoside antimetabolites—approved antineoplastic agents—that have recently been shown to have antiviral and/or antibacterial activity. The approved drugs and drug combinations, as well as recently identified candidates for investigation and/or experimentation, are discussed. Several examples of repurposed drugs that have already been approved for use are presented. This strategy can be crucial for the first-line treatment of acute infections or coinfections and for the management of drug-resistant strains. The Authors. Published by Elsevier B.V. 2019-12-15 2019-10-18 /pmc/articles/PMC7173238/ /pubmed/31634460 http://dx.doi.org/10.1016/j.ejphar.2019.172747 Text en © 2019 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Full Length Article Pastuch-Gawołek, Gabriela Gillner, Danuta Król, Ewelina Walczak, Krzysztof Wandzik, Ilona Selected nucleos(t)ide-based prescribed drugs and their multi-target activity |
title | Selected nucleos(t)ide-based prescribed drugs and their multi-target activity |
title_full | Selected nucleos(t)ide-based prescribed drugs and their multi-target activity |
title_fullStr | Selected nucleos(t)ide-based prescribed drugs and their multi-target activity |
title_full_unstemmed | Selected nucleos(t)ide-based prescribed drugs and their multi-target activity |
title_short | Selected nucleos(t)ide-based prescribed drugs and their multi-target activity |
title_sort | selected nucleos(t)ide-based prescribed drugs and their multi-target activity |
topic | Full Length Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173238/ https://www.ncbi.nlm.nih.gov/pubmed/31634460 http://dx.doi.org/10.1016/j.ejphar.2019.172747 |
work_keys_str_mv | AT pastuchgawołekgabriela selectednucleostidebasedprescribeddrugsandtheirmultitargetactivity AT gillnerdanuta selectednucleostidebasedprescribeddrugsandtheirmultitargetactivity AT krolewelina selectednucleostidebasedprescribeddrugsandtheirmultitargetactivity AT walczakkrzysztof selectednucleostidebasedprescribeddrugsandtheirmultitargetactivity AT wandzikilona selectednucleostidebasedprescribeddrugsandtheirmultitargetactivity |